JASPER THERAPEUTICS, INC.
(JSPR)Financial Statements · SEC EDGAR XBRL
Net Income
-$75.8M
-6.4%
EPS
$-3.95
+19.2%
Op. Income
-$83.9M
-10.0%
Source: SEC EDGAR XBRL
Breakdown
Revenues
Cost of Revenues
Operating Expenses & Income
Research & Development
Total Operating Expenses
Operating Income
Non-Operating Income/Expense
Other Non-Operating Income
Income Tax Expense
Net Income
EPS (Basic)
EPS (Diluted)
Shares Outstanding (Diluted)